The board of directors at Metaplanet has found itself at the centre of a heated debate, as shareholders express strong dissatisfaction with a proposed executive compensation plan that many consider controversial. While the independent directors on the board have defended the plan by highlighting the financial risks associated with the company’s current management strategy and the essential role of restructuring in securing Metaplanet’s future, they have not fully addressed lingering concerns about the specifics of the deal—particularly the shares that senior executive Gerovich has already exercised and the involvement of the investment vehicle known as MMXX Ventures. At the heart of the dispute is a payout structure that would grant a substantial amount of equity to a small group of top executives, contingent upon meeting certain performance milestones. Shareholders argue that this arrangement could dilute existing ownership, reward management for short‑term gains, and potentially misalign the interests of executives with those of the broader investor base.
In response, the board’s independent directors have issued a statement emphasizing that the proposed payout is designed to mitigate the financial risk that Metaplanet faces under its current operational model. They argue that without a strong incentive package, the company might struggle to attract and retain the talent needed to navigate a complex restructuring process that is essential for long‑term profitability. The directors contend that the restructuring effort is not merely a cosmetic change but a fundamental overhaul of Metaplanet’s business model. It involves streamlining product lines, renegotiating supplier contracts, and investing in new technology platforms that could position the company more competitively in its market.
According to the board, these initiatives require a leadership team that is both motivated and financially vested in the success of the turnaround. The executive payout plan, therefore, is presented as a tool to align the personal financial outcomes of senior managers with the broader strategic objectives of the company.
Despite these arguments, shareholders remain unconvinced. One of the primary points of contention is the lack of transparency surrounding Gerovich’s exercised shares. Gerovich, a senior executive who has been with Metaplanet for over a decade, reportedly exercised a sizable block of stock options prior to the announcement of the restructuring plan.
Critics claim that this timing could allow Gerovich to benefit from any subsequent rise in share price that might be driven by the very restructuring initiatives the payout plan is meant to fund. The board’s response has been limited to acknowledging the exercise but refusing to disclose the exact number of shares or the price at which they were exercised, citing confidentiality agreements and market sensitivity.
Equally opaque is the role of MMXX Ventures, a venture capital entity that has been identified as a key partner in the restructuring effort. While the board has confirmed that MMXX Ventures will provide strategic guidance and potentially additional capital, the specifics of the partnership remain vague.
Shareholders have asked for clarification on whether MMXX Ventures will receive any preferential treatment, such as exclusive rights to future financing rounds or a guaranteed seat on the board, and how those arrangements might affect the overall governance and financial health of Metaplanet. The board’s defensive stance has not quelled the unrest. Several institutional investors have signaled their intent to vote against the executive payout plan at the upcoming annual general meeting. They have called for a more detailed disclosure of the terms of Gerovich’s share exercise, a clear outline of MMXX Ventures’ involvement, and an independent audit of the projected financial impact of the payout scheme.
In addition, activist shareholders have proposed a resolution to amend the company’s compensation policy, demanding stricter caps on equity awards and the introduction of clawback provisions should the restructuring fail to deliver the promised results. In an effort to defuse the situation, the independent directors have offered to hold a series of town‑hall meetings with shareholders, aiming to provide a forum for questions and to present a more granular breakdown of the restructuring timeline, cost estimates, and expected return on investment. They have also pledged to release a supplemental report that will detail the methodology used to calculate the executive payout, including the assumptions about revenue growth, cost savings, and market share expansion. Nevertheless, the core issue remains: the perception that the executive payout plan could disproportionately benefit a small group of insiders at the expense of ordinary shareholders.
Trust in corporate governance is fragile, and any hint of preferential treatment can erode confidence, potentially leading to a decline in stock price and reduced market valuation. For Metaplanet to move forward successfully, the board must not only articulate a compelling business case for the restructuring but also demonstrate a commitment to fairness, transparency, and accountability.
Looking ahead, the outcome of the upcoming vote will be a litmus test for how much influence shareholders can exert over executive compensation in a high‑stakes turnaround scenario. If the board’s proposals are rejected, Metaplanet may need to revisit its compensation framework, possibly scaling back the equity awards or restructuring them to include more performance safeguards.
Conversely, if the plan is approved, the company will need to closely monitor the execution of its restructuring agenda, ensuring that the promised benefits materialize and that the incentives do not become a source of further controversy. In summary, the Metaplanet board’s resistance to shareholder anger over the executive payout plan underscores a broader tension between the need for aggressive talent incentives during a critical restructuring phase and the imperative to maintain equitable treatment of all investors. The unresolved questions about Gerovich’s exercised shares and the exact nature of MMXX Ventures’ partnership remain pivotal points that will likely shape the discourse at the upcoming shareholder meeting and influence the company’s strategic trajectory for years to come.